Johnson & Johnson expands its empire
Bloomberg.com - Johnson & Johnson will buy Omrix Biopharmaceuticals Inc. for $438 million, gaining protein-based products that stanch bleeding during ...
Bloomberg.com - Johnson & Johnson will buy Omrix Biopharmaceuticals Inc. for $438 million, gaining protein-based products that stanch bleeding during ...